Loading clinical trials...
Loading clinical trials...
A Single-Dose Efficacy Comparison of Albuterol Hydrofluoroalkane (HFA) Breath-operated Inhaler (BOI) (Volare Easi-Breathe™) and Albuterol HFA Meter Dose Inhaler (MDI) (Volare™) in Adolescents and Adults With Exercise-Induced Bronchospasm
Conditions
Interventions
albuterol aerosol by HFA MDI
albuterol aerosol by HFA BOI
+1 more
Locations
3
United States
Colorado Allergy and Asthma Centers, PC
Denver, Colorado, United States
Colorado Allergy and Asthma Centers, PC
Englewood, Colorado, United States
Colorado Allergy and Asthma Centers, PC
Lakewood, Colorado, United States
Start Date
June 30, 2004
Primary Completion Date
September 30, 2004
Completion Date
September 30, 2004
Last Updated
November 24, 2021
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions